RUO urelumab是一种靶向4-1BB的人源化激动性单克隆抗体,具有潜在的免疫刺激和抗肿瘤活性。Urelumab特异性结合并激活表达CD 137的免疫细胞,刺激针对肿瘤细胞的免疫应答,特别是细胞毒性T细胞应答。. Urelumab生物仿制药-研究级该产品同种型对照:Bulk Human IgG1 Isotype Control (IB1) [ICH2254] 缓冲液:ICH3002 浓度:5mg/ml 纯度:>95% by SDS-PAGE 内毒素:≤ 1.0 EU/mg as determined by the LAL method 制剂:Sterile, preservative-free, solution in PBS. BSA and Azide free.